Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of NANO-PSO (omega 5) Supplementation on Cognitive Abilities of Older Adults with Mild to Moderate Non-vascular Cognitive Impairment

NCT06520878 is registered in ClinicalTrials.gov with Distribuidora Biolife SA de CV as lead sponsor.

NCT NCT06520878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06520878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of NANO-PSO (omega 5) Supplementation on Cognitive Abilities of Older Adults with Mild to Moderate Non-vascular Cognitive Impairment
Lead sponsor
Distribuidora Biolife SA de CV
Phase
Phase 2
Overall status
Recruiting
Start date
February 12, 2025
Completion date
December 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognition